Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection

Journal of Clinical Virology

Volumn 48, Issue 1, 2010, Pages 15-17

  Lee, S R ^a   Yearwood, G D ^a   Guillon, G B ^a   Kurtz, L A ^a   Fischl, M ^a   Friel, T ^b   Berne, C A ^c   Kardos, K W ^a  

^a ORASURE TECHNOLOGIES INC   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

^c Biological Specialty Corporation   (United States)

Author keywords

Diagnosis; HCV; Rapid

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BLOOD; BODY FLUID; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; FINGERSTICK BLOOD; FOOD AND DRUG ADMINISTRATION; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; ORAL FLUID; PLASMA; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SERUM; VENOUS BLOOD;

HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMOBILIZED PROTEINS; IMMUNOENZYME TECHNIQUES; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 77950551758     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.02.018     Document Type: Article

References (22)

1. Choo Q.-L., Kuo G., Weiner A.J., Overby R., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
2. Kleinman S., Alter H., Busch M.P., Holland P., Tegtmeier G., Nelles M., et al. Increased detection of HCV infected blood donors using a multiple antigen HCV enzyme immunoassay. Transfusion 32 (1992) 805-813
3. Lee S.R., Wood C.L., Lane J., Francis B., Gust C., Higgs C., et al. Increased detection of hepatitis C virus (HCV) infected commercial plasma donors by a third generation screening assay. Transfusion 35 (1995) 845-849
4. Stramer S.L., Glynn S.A., Kleinman S.H., Strong M., Caglioti S., Wright D.J., et al. Detection of HIV-1 and HCV infections among antibody negative blood donors by nucleic acid amplification testing. NEJM 351 (2004) 760-768
5. Wasley A., Grytdal S., and Gallagher K. Surveillance for acute viral hepatitis-United States 2006. MMWR Surveill Summ 57 (2008) 1
6. Dodd R.Y., Notari E.P., and Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross donor population. Transfusion 42 (2002) 975-979
7. WHO. Weekly Epidemiology Record (1999) No. 49
8. Armstrong G.L., Wasley A., Simard E.P., McQuilan G.M., Kuhnert W.L., and Alter M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006) 705-715
9. Kwiatkowski C.F., Fortuin-Corsey K., and Booth R.E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 97 (2002) 1289-1294
10. Kuehn B.M. Silent epidemic of viral hepatitis may lead to boom in serious liver disease. JAMA 302 (2009) 1949-1954
11. Davis G.L., Albright J.E., Cook S.F., and Rosenberg D.M. Projecting future complications of chronic hepatitis C in the United States. Liver Transplant 9 (2003) 331-338
12. Shuhart M.C., Bronner M.P., Gretch D.R., Thomassen L.V., Wartelle C.F., Tateyama H., et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 26 (1997) 1646-1652
13. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F., et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis virus infection. N Engl J Med 347 (2002) 975-982
14. Thompson A.J., and McHutchison J.G. Review article: investigational agents for chronic hepatitis C. Aliment Pharmacol Ther 29 (2009) 689-695
15. Lyss S.B., Branson B., Kroc K., Couture E.F., Newman D.R., and Weinstein R.A. Detecting unsuspected HIV infection with a rapid whole blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr 44 (2007) 435-442
16. Gray J.W. Infectious diseases and point-of-care testing. In: Price C.P., St John A., and Hicks J.M. (Eds). Point of care testing. 2nd edition (2004), AACC Press 361-374 Chapter 36
17. Kondili L.A., Chionne P., Costantino A., Villano U., Lo Noce C., Pannozzo F., et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C infection in the general population. Gut 50 (2002) 693-696
18. Myrmel H., Navaratnam V., and Asjo B. Detection of antibodies to hepatitis C virus: false negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle immunoassay (AxSYM HCV Version 3.0). J Clin Virol 34 (2005) 211-215
19. Zachary P., Ullmann M., Djeddi S., Meyer N., Wendling M.-J., Schvoerer, et al. Evaluation of three commercially available hepatitis C antibody detection assays under the conditions of the clinical virology laboratory. J Clin Virol 34 (2005) 207-210
20. Barrera J.M., Francis B., Ercilla G., Nelles M., Achord D., Darner J., et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third generation ELISA. Vox Sanguinis 68 (1995) 15-18
21. O'Connel R.J., Gates R.G., Imbach M., Bautista C.T., Beardsley S.G., Gonzales R., et al. Laboratory evaluation of hepatitis C rapid tests for use in screening walking blood bank donors. Advanced Technology Applications for Combat Casualty Care Conference (2008)
22. Johnston-Roberts K., Grusky O., and Swanson A.-N. Outcomes of blood and oral fluid rapid HIV testing: a literature review, 2000-2006. AIDS Patient Care STDs 21 (2007) 621-637